文献速递心脑血管急症重症综合管理与镇静镇痛

成人及儿童创伤性脑损伤治疗性低温的荟萃分析

Meta-Analysis of Therapeutic Hypothermia for Traumatic Brain Injury in Adult and Pediatric Patients.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论成人创伤性脑损伤治疗性低温与死亡率降低18%及神经功能改善35%相关,但儿童患者与死亡率增加66%相关,作者认为成人可能获益而儿童不能推荐。

该荟萃分析纳入41项成人研究(n=3,109,年龄18-81岁)和8项儿童研究(n=454,年龄3月龄至18岁),评估治疗性低温对创伤性脑损伤的死亡率、神经功能结局及不良反应的影响。成人中,与常温组相比,低温组死亡率降低18%(RR 0.82,95%CI 0.70-0.96,p=0.01),神经功能结局改善35%(RR 1.35,95%CI 1.18-1.54,p<0.00001)。成人最佳管理策略为降温至最低33°C持续72小时,随后自然复温。儿童中,低温组死亡率增加66%(RR 1.66,95%CI 1.06-2.59,p=0.03),神经功能结局边缘性恶化(RR 0.90,95%CI 0.80-1.01,p=0.06)。作者结论认为成人创伤性脑损伤后治疗性低温可能是有益治疗,但不能推荐用于儿童。

要点

  • 成人创伤性脑损伤:与常温相比,治疗性低温与死亡率降低18%相关(RR 0.82,95%CI 0.70-0.96,p=0.01)。
  • 成人创伤性脑损伤:治疗性低温与神经功能结局改善35%相关(RR 1.35,95%CI 1.18-1.54,p<0.00001)。
  • 成人最佳管理策略包括降温至最低33°C持续72小时,随后自然复温。
  • 儿童创伤性脑损伤:低温组死亡率增加66%(RR 1.66,95%CI 1.06-2.59,p=0.03),神经功能结局边缘性恶化(RR 0.90,95%CI 0.80-1.01,p=0.06)。
  • 作者结论:成人创伤性脑损伤后治疗性低温可能是有益治疗,但不能推荐用于儿童。

适用人群与场景

  • 成人研究41项,共3,109例,年龄范围18-81岁,创伤性脑损伤患者。
  • 儿童研究8项,共454例,年龄范围3月龄至18岁,创伤性脑损伤患者。

处置流程与药物剂量

  • 成人最佳管理策略包括降温至最低33°C持续72小时,随后自然复温。

研究设计与关键结果

  • 研究类型为荟萃分析,纳入41项成人研究(n=3,109,年龄18-81岁)和8项儿童研究(n=454,年龄3月龄至18岁)。
  • 成人中,与常温组相比,治疗性低温组死亡率降低18%(RR 0.82,95%CI 0.70-0.96,p=0.01),神经功能结局改善35%(RR 1.35,95%CI 1.18-1.54,p<0.00001)。
  • 儿童中,与常温组相比,治疗性低温组死亡率增加66%(RR 1.66,95%CI 1.06-2.59,p=0.03),神经功能结局边缘性恶化(RR 0.90,95%CI 0.80-1.01,p=0.06)。

证据类型、等级与局限

  • 证据类型:荟萃分析,检索PubMed、Google Scholar、Web of Science、Cochrane Central Register of Controlled Trials、ClinicalTrials.gov及手动检索至2016年2月。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为成人创伤性脑损伤后治疗性低温可能是有益治疗,但不能推荐用于儿童。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Therapeutic hypothermia has been used to attenuate the effects of traumatic brain injuries. However, the required degree of hypothermia, length of its use, and its timing are uncertain. We undertook a comprehensive meta-analysis to quantify benefits of hypothermia therapy for traumatic brain injuries in adults and children by analyzing mortality rates, neurologic outcomes, and adverse effects.

DATA SOURCES: Electronic databases PubMed, Google Scholar, Web of Science, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov and manual searches of studies were conducted for relevant publications up until February 2016.

STUDY SELECTION: Forty-one studies in adults (n = 3,109; age range, 18-81 yr) and eight studies in children (n = 454; age range, 3 mo to 18 yr) met eligibility criteria.

DATA EXTRACTION: Baseline patient characteristics, enrollment time, methodology of cooling, target temperature, duration of hypothermia, and rewarming protocols were extracted.

DATA SYNTHESIS: Risk ratios with 95% CIs were calculated. Compared with adults who were kept normothermic, those who underwent therapeutic hypothermia were associated with 18% reduction in mortality (risk ratio, 0.82; 95% CI, 0.70-0.96; p = 0.01) and a 35% improvement in neurologic outcome (risk ratio, 1.35; 95% CI, 1.18-1.54; p < 0.00001). The optimal management strategy for adult patients included cooling patients to a minimum of 33°C for 72 hours, followed by spontaneous, natural rewarming. In contrast, adverse outcomes were observed in children who underwent hypothermic treatment with a 66% increase in mortality (risk ratio, 1.66; 95% CI, 1.06-2.59; p = 0.03) and a marginal deterioration of neurologic outcome (risk ratio, 0.90; 95% CI, 0.80-1.01; p = 0.06).

CONCLUSIONS: Therapeutic hypothermia is likely a beneficial treatment following traumatic brain injuries in adults but cannot be recommended in children.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Crompton EM, Lubomirova I, Cotlarciuc I, et al. Meta-Analysis of Therapeutic Hypothermia for Traumatic Brain Injury in Adult and Pediatric Patients. Crit Care Med. 2017. PMID: 27941370. doi:10.1097/CCM.0000000000002205

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。